BioMarin Pharmaceutical D
D
BMRN
57.500
USD
-0.49
(-0.85%)
مغلق
حجم التداول
69,354
الربح لكل سهم
4
العائد الربحي
-
P/E
22
حجم السوق
11,027,100,738
الأخبار المقالات
العنوان: BioMarin Pharmaceutical
القطاع: Healthcare
الصناعة: Biotechnology
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline oftreatments in development.